Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?

MLA

Adams, Hugo J. A., et al. “Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?” Journal of Computer Assisted Tomography, vol. 39, no. 5, Sept. 2015, pp. 810–15. EBSCOhost, https://doi.org/10.1097/RCT.0000000000000270.

APA

Adams, H. J. A., de Klerk, J. M. H., Fijnheer, R., Heggelman, B. G. F., Dubois, S. V., Nievelstein, R. A. J., & Kwee, T. C. (2015). Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value? Journal of Computer Assisted Tomography, 39(5), 810–815. https://doi.org/10.1097/RCT.0000000000000270

Chicago

Adams, Hugo J. A., John M. H. de Klerk, Rob Fijnheer, Ben G. F. Heggelman, Stefan V. Dubois, Rutger A. J. Nievelstein, and Thomas C. Kwee. 2015. “Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?” Journal of Computer Assisted Tomography 39 (5): 810–15. doi:10.1097/RCT.0000000000000270.